Related Experiment Video
Updated: May 9, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Inherited predisposition to myeloproliferative neoplasms
Amy V Jones1, Nicholas C P Cross
1Wessex Regional Genetics Laboratory, Salisbury, UK, Faculty of Medicine, University of Southampton, Southampton, UK.
Therapeutic Advances in Hematology
|August 9, 2013
Summary
Inherited factors play a role in myeloproliferative neoplasms (MPNs). The JAK2 46/1 haplotype is a key predisposition factor, but other genetic variants also contribute to MPN development.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Myeloproliferative neoplasms (MPNs) involve myeloid cell overproduction and can transform into acute myeloid leukemia.
- While somatic mutations like JAK2 V617F drive MPN, inherited factors also influence disease development and diversity.
- Familial predisposition and epidemiological studies suggest genetic susceptibility alleles contribute to MPN.
Purpose of the Study:
- To review the current understanding of inherited factors in the development of sporadic and familial MPNs.
- To highlight the role of genetic predisposition in MPN pathogenesis.
- To discuss the genetic basis of MPNs beyond acquired mutations.
Main Methods:
- Review of existing literature on genetic predisposition in MPNs.
- Analysis of epidemiological studies identifying susceptibility alleles.
- Discussion of known genetic variants and emerging genome-wide association studies.
Main Results:
- The JAK2 46/1 haplotype (GGCC) is the strongest known predisposition factor for JAK2 V617F-positive MPNs.
- Genetic variants influencing erythropoietin and thrombopoietin signaling are implicated in hereditary erythrocytosis/thrombocytosis.
- Research is ongoing to identify genetic variants predisposing to MPNs lacking JAK2 V617F.
Conclusions:
- Inherited factors significantly contribute to MPN heritability.
- Understanding genetic predisposition is crucial for elucidating MPN pathogenesis and diversity.
- Advanced sequencing technologies are expected to reveal novel insights into the genetic basis of MPNs.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...